1Philips NR,Waters D,Havel RJ.Plasma lipoproteins and progression of cardiovascular disease evaluated by angiography and clinical events.Circulation,1993,88:2 762-770
4Segrest JP,Li L,Anantharamaiah GM,Harvey SC,Liadaki KN,Zannis V.Structure and function of apolipoprotein AⅠ and high density lipoprotein.Curr Opin Lipidol,2000,11:105-115
5Datta D,Chaddha M,Hama S,Navab M,Fogelman AM,Garber DW,et al.Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.J lipid Res,2001,42:1 096-104
6Navab M,Anantharamaiah GM,Hama S,Garber DW,Chaddha M,Hpugh G,et al.Oral administration of an apo AⅠ mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.Circulation,2002,105:290-292
7Anderew HE,Bruckdorfer KR,Dunn RC,Jacobs M.Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.Nature,1987,327:237-239
4Belalcazar LM, Merched A, Cart B, et al. Long-term stable expression of human apolipoprotein A-1 mediated by helper-dependent adenovi- rus gene transfer inhibits atherosclerosis progression and remodels athemsclerotic plaques in a mouse model of familial hypercholesterol- emia [ J ]. Circulation,2003,107 (21) :2726-2732.
5Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA- I Milano on coronary atherosclemsis in patients with acute coronary syndromes: a randomized controlled trial [ J ]. JAMA,2003,290 ( 17 ) : 2292-2300.
6Sethi AA, Amar M, Shamburek RD, et al. Apolipoprotein A I mimetic peptides: Possible new agents for the treatment of atherosclerosis [ J ]. Curt Opin Investig Drugs,2007,8 (3) :201-212.
7Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of my- eloperoxidase in patients with chest pain [ J ]. N Engl J Med,2003, 349( 17 ) : 1595-1604.
8Ansell B J, Navab M, Hama S, et al. Inflammatory/anti-inflammatory properties of high-density lipoprotein in cholesterol levels and are fa-vorably affected by simvastatin treatment [ J ]. Circulation, 2003,108 ( 22 ) :2751-2756.
9Navab M, Anantharamaish GM, Hama S, et al. Oral administration of an apo A1 mimetic peptide synthesized from D-amino acids dramatic- ally reduces atherosclerosis in mice independent of plasma cholesterol [ J ]. Circulation,2002,105 (3) :290-292.
10Ou JS,Ou ZJ,Jones DW,et al. Cell-free hemoglobin limits nitric ox- ide bioavailability in sickle-cell disease [ J ]. Nat Med ,2002,8 ( 12 ) : 1383-389.
